Publication

Postmortem proteomics to discover biomarkers for forensic PMI estimation

조회수 : 122 등록일 : 2019.05.01 00:00

저자 : Yun, KN (Yun, Ki Na)
출처 : INTERNATIONAL JOURNAL OF LEGAL MEDICINE
출판일 : 2019.05.01


Postmortem proteomics to discover biomarkers for forensic PMI estimation


Choi, KM (Choi, Kyoung-Min)1 ] Zissler, A (Zissler, Angela)2 ] Kim, E (Kim, Eunjung)3 ] Ehrenfellner, B (Ehrenfellner, Bianca)2 ] Cho, E (Cho, Eunji)1 ] Lee, SI (Lee, Se-in)1 ] Steinbacher, P (Steinbacher, Peter)2 ] Yun, KN (Yun, Ki Na)4,5 ] Shin, JH (Shin, Jong Hwan)1,5 ] Kim, JY (Kim, Jin Young)5 ] Stoiber, W (Stoiber, Walter)2 ] Chung, H (Chung, Heesun)1 ] Monticelli, FC (Monticelli, Fabio Carlo)6 ] Kim, JY (Kim, Jae-Young)1,7 ] Pittner, S(Pittner, Stefan)6 ]


[ 1 ] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol GRAST, Daejeon, South Korea
[ 2 ] Univ Salzburg, Dept Biosci, Salzburg, Austria
[ 3 ] H Lee Moffitt Cancel Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL USA
[ 4 ] Sogang Univ, Dept Chem, Seoul, South Korea
[ 5 ] Korea Basic Sci Inst, Biomed Omics Ctr, Ochang, South Korea
[ 6 ] Univ Salzburg, Dept Forens Med, Salzburg, Austria
[ 7 ] Korea Basic Sci Inst, Div Bioconvergence Anal, Ochang, South Korea



The assessment of postmortem degradation of skeletal muscle proteins has emerged as a novel approach to estimate the time since death in the early to mid-postmortem phase (approximately 24 h postmortem (hpm) to 120 hpm). Current protein-based methods are limited to a small number of skeletal muscle proteins, shown to undergo proteolysis after death. In this study, we investigated the usability of a target-based and unbiased system-wide protein analysis to gain further insights into systemic postmortem protein alterations and to identify additional markers for postmortem interval (PMI) delimitation. We performed proteomic profiling to globally analyze postmortem alterations of the rat and mouse skeletal muscle proteome at defined time points (0, 24, 48, 72, and 96 hpm), harnessing a mass spectrometry-based quantitative proteomics approach. Hierarchical clustering analysis for a total of 579 (rat) and 896 (mouse) quantified proteins revealed differentially expressed proteins during the investigated postmortem period. We further focused on two selected proteins (eEF1A2 and GAPDH), which were shown to consistently degrade postmortem in both rat and mouse, suggesting conserved intra- and interspecies degradation behavior, and thus preserved association with the PMI and possible transferability to humans. In turn, we validated the usefulness of these new markers by classical Western blot experiments in a rat model and in human autopsy cases. Our results demonstrate the feasibility of mass spectrometry-based analysis to discover novel protein markers for PMI estimation and show that the proteins eEF1A2 and GAPDH appear to be valuable markers for PMI estimation in humans.






  • 목록보기
  • 이전글보기
  • 다음글보기